T0	Participants 60 117	men treated for symptomatic benign prostatic hyperplasia.
T1	Participants 224 313	men with lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH).
T2	Participants 373 397	men aged > or = 50 years
T3	Participants 690 702	372 patients
T4	Participants 773 798	355 completing the study.
T5	Participants 799 914	At baseline, 64% of the patients reported erectile dysfunction (ED) and 63% reported ejaculatory dysfunction (EjD).